ClinConnect ClinConnect Logo
Search / Trial NCT05352139

Treatment of Tendinosis Using the TenJet Hydroresection System

Launched by ROTHMAN INSTITUTE ORTHOPAEDICS · Apr 25, 2022

Trial Information

Current as of July 22, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient is 18 - 70 years of age
  • Chronic tendon pain ≥ 3 months duration
  • History and clinical examination consistent with tendinosis
  • Sonographic or MRI confirmation of tendinosis
  • 3 months of conservative treatment
  • Patient is willing and able to provide informed consent and comply with the study protocol
  • Exclusion Criteria:
  • Full thickness tear of the tendon
  • Unable to withhold anticoagulants 7 days prior to the procedure.
  • Use above 81mg/day of acetylsalicyclic acid (ASA) and/or non-steroidal anti-inflammatory drug (NSAID) within 7 days of treatment
  • Steroid, PRP, Stem cell or biologic injections within 3 months of the study procedure date
  • Needle tenotomy, Tenex, or surgical interventions within 6 months of study procedure date
  • Active local or systemic infection requiring antiviral, antibacterial or antifungal treatment
  • Chronic conditions such as CRPS or fibromyalgia that might affect pain symptoms.

About Rothman Institute Orthopaedics

Rothman Institute Orthopaedics is a leading healthcare organization specializing in orthopedic care and research. With a commitment to advancing the field of orthopedics, Rothman Institute conducts innovative clinical trials aimed at improving patient outcomes and enhancing treatment methodologies. Renowned for its team of highly skilled orthopedic surgeons and researchers, the institute integrates cutting-edge technology and evidence-based practices to deliver exceptional care. Through its rigorous research initiatives, Rothman Institute is dedicated to fostering advancements in orthopedic medicine and contributing to the overall improvement of musculoskeletal health.

Locations

Philadelphia, Pennsylvania, United States

Baton Rouge, Louisiana, United States

Chapel Hill, North Carolina, United States

Redwood City, California, United States

Coral Springs, Florida, United States

Lorain, Ohio, United States

Clarion, Pennsylvania, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials